AIM To examine the outcome and prognostic factors for high risk patients with acute lymphoblastic leukemia/lymphoma(ALL/LBL)who underwent allogeneic hematopoiet
Innovative and exciting advances in the clinical science in solid organ transplantation continuously realize as the results of studies,clinical trials,internati